Biotech Values

[Nerf]

All this talk about DNDN; now RPRX has a market cap of 180, DNDN has a market cap of 730, the market size is similar if not bigger than DNDN's and there's less regulatory hurdles, less competition in their primary space....

to have RPRX selling for 180 by comparison with any other Biotech is laughable

should be at least as tall as DND if not more. But here we sit waiting to bust through 15. Fair valuation would be 2+ times what it's selling for!

If DNDN is a good buy, RPRX is a screamer